Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Steven

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Anticancer Research|November 29, 2005
Under-representation of bladder transitional cell tumour 9q, 11p and 14q LOH in urine and impact on molecular diagnosisDelfina Fornari, Kenneth Steven, Alastair B Hansen, et al.
Anticancer Research|July 28, 2004
New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladderDelfina Fornari, Kenneth Steven, Alastair B Hansen, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2010
Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancerReza R Serizawa, Ulrik Ralfkiaer, Christina Dahl, et al.
European Urology|May 28, 2003
Relative importance of sources of symptom-induced distress in urinary bladder cancer survivorsLars Henningsohn, Hans Wijkström, Kenneth Steven, et al.
International Journal of Cancer|September 9, 2010
Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation eventsReza R Serizawa, Ulrik Ralfkiaer, Kenneth Steven, et al.
Acta Oncologica (Stockholm, Sweden)|November 22, 2002
Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumoursLisa Sengeløv, Hans von der Maase, Finn Lundbeck, et al.
Clinical Epigenetics|September 17, 2022
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsHeidi Dietrichson Pharo, Marine Jeanmougin, Eirill Ager-Wick, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Anticancer Research|November 29, 2005
Under-representation of bladder transitional cell tumour 9q, 11p and 14q LOH in urine and impact on molecular diagnosisDelfina Fornari, Kenneth Steven, Alastair B Hansen, et al.
Anticancer Research|July 28, 2004
New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladderDelfina Fornari, Kenneth Steven, Alastair B Hansen, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2010
Custom-designed MLPA using multiple short synthetic probes: application to methylation analysis of five promoter CpG islands in tumor and urine specimens from patients with bladder cancerReza R Serizawa, Ulrik Ralfkiaer, Christina Dahl, et al.
European Urology|May 28, 2003
Relative importance of sources of symptom-induced distress in urinary bladder cancer survivorsLars Henningsohn, Hans Wijkström, Kenneth Steven, et al.
International Journal of Cancer|September 9, 2010
Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation eventsReza R Serizawa, Ulrik Ralfkiaer, Kenneth Steven, et al.
Acta Oncologica (Stockholm, Sweden)|November 22, 2002
Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumoursLisa Sengeløv, Hans von der Maase, Finn Lundbeck, et al.
Clinical Epigenetics|September 17, 2022
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsHeidi Dietrichson Pharo, Marine Jeanmougin, Eirill Ager-Wick, et al.
Pageof 2